只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-06-04 2026-06-08 | PHVS Pharvaris N.V. | Nijdam Anna Officer · Principal Accounting Officer | 卖出（S） | 2,670 | US$30.87 | US$82,422.90 | 46,275 | SEC |
| 2026-05-22 2026-05-26 | PHVS Pharvaris N.V. | Nijdam Anna Officer · Principal Accounting Officer | 卖出（S） | 5,501 | US$30.74 | US$169,100.74 | 48,945 | SEC |
| 2026-05-21 2026-05-26 | PHVS Pharvaris N.V. | Nijdam Anna Officer · Principal Accounting Officer | 卖出（S） | 1,829 | US$30.60 | US$55,967.40 | 48,945 | SEC |
| 2026-05-07 2026-05-07 | OFIX Orthofix Medical Inc. | Ajdler Arnaud TenPercentOwner | 买入（P） | 904 | US$12.15 | US$10,983.60 | 382,450 | SEC |
| 2026-05-07 2026-05-07 | OFIX Orthofix Medical Inc. | Ajdler Arnaud TenPercentOwner | 买入（P） | 1,808 | US$12.20 | US$22,057.60 | 381,546 | SEC |
| 2026-05-07 2026-05-07 | OFIX Orthofix Medical Inc. | Ajdler Arnaud TenPercentOwner | 买入（P） | 9,096 | US$12.15 | US$110,516.40 | 3,848,573 | SEC |
| 2026-05-07 2026-05-07 | OFIX Orthofix Medical Inc. | Ajdler Arnaud TenPercentOwner | 买入（P） | 18,192 | US$12.20 | US$221,942.40 | 3,839,477 | SEC |
| 2026-05-06 2026-05-07 | OFIX Orthofix Medical Inc. | Ajdler Arnaud TenPercentOwner | 买入（P） | 38,154 | US$12.23 | US$466,623.42 | 3,821,285 | SEC |
| 2026-05-06 2026-05-07 | OFIX Orthofix Medical Inc. | Ajdler Arnaud TenPercentOwner | 买入（P） | 3,792 | US$12.23 | US$46,376.16 | 379,738 | SEC |
| 2026-05-05 2026-05-07 | OFIX Orthofix Medical Inc. | Ajdler Arnaud TenPercentOwner | 买入（P） | 110,039 | US$11.99 | US$131.94万 | 3,783,131 | SEC |
| 2026-05-05 2026-05-07 | OFIX Orthofix Medical Inc. | Ajdler Arnaud TenPercentOwner | 买入（P） | 2,911 | US$11.99 | US$34,902.89 | 375,946 | SEC |
| 2026-04-16 2026-04-16 | BEAT HeartBeam, Inc. | Vajdic Branislav Director | 买入（P） | 31,250 | US$0.80 | US$25,000.00 | 909,914 | SEC |
| 2026-03-14 2026-05-18 | BJDX Bluejay Diagnostics, Inc. | Dey Svetlana Director | 买入（P） | 12,500 | US$2.00 | US$25,000.00 | 12,501 | SEC |
| 2026-03-14 2026-05-18 | BJDX Bluejay Diagnostics, Inc. | ZEIDMAN FRED S Director | 买入（P） | 12,500 | US$2.00 | US$25,000.00 | 12,500 | SEC |
| 2026-03-14 2026-05-18 | BJDX Bluejay Diagnostics, Inc. | CHASE DONALD R Director | 买入（P） | 12,500 | US$2.00 | US$25,000.00 | 12,525 | SEC |
| 2026-03-14 2026-05-18 | BJDX Bluejay Diagnostics, Inc. | Dey Indranil Director,Officer · President and CEO | 买入（P） | 12,500 | US$2.00 | US$25,000.00 | 12,522 | SEC |
| 2026-03-14 2026-05-18 | BJDX Bluejay Diagnostics, Inc. | Wurth Douglas Clark Director | 买入（P） | 12,500 | US$2.00 | US$25,000.00 | 12,608 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| JDVL | 908.159 | 0 | 986.159 | 92.09% | Q |
| KJD | 923 | 0 | 1,710.9841 | 53.95% | Q |
| JDOC | 35 | 0 | 68.7796 | 50.89% | Q |
| JDZG | 59,185.1557 | 10,270.0361 | 134,344.1021 | 44.05% | B, Q, N |
| JDIV | 54 | 0 | 125.2232 | 43.12% | Q |
| WWJD | 11,552.6656 | 0 | 27,408.4031 | 42.15% | Q, N |
| JDST | 41,454.1494 | 0 | 102,792.0267 | 40.33% | B, Q, N |
| JD | 1,036,234.3236 | 845 | 2,836,993.0426 | 36.53% | B, Q, N |
| DJD | 7,534.0699 | 0 | 22,270.7182 | 33.83% | B, Q, N |
| RJDI | 2,082.6878 | 0 | 6,891.6815 | 30.22% | Q |
| BJDX | 9,924 | 0 | 39,142.6579 | 25.35% | Q, N |
| JDVI | 1,161 | 0 | 4,609.349 | 25.19% | Q |
| SOJD | 11,418.1557 | 1,000 | 52,199.4012 | 21.87% | Q, N |